UNCYLawsuits•prnewswire•
Investor Alert: Robbins LLP Informs Investors of the Unicycive Therapeutics, Inc. Class Action
Sentiment:Negative (-70)
Summary
SAN DIEGO, Aug. 18, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Unicycive Therapeutics, Inc. (NASDAQ: UNCY) securities between March 29, 2024 and June 27, 2025. Unicycive is a clinical-stage...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 18, 2025 by prnewswire